ResMed (NYSE:RMD) reported its Q2 earnings results on Thursday, January 27, 2022 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
ResMed missed estimated earnings by 3.29%, reporting an EPS of $1.47 versus an estimate of $1.52, which did not surprise analysts.
Revenue was up $94.86 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.15, which was followed by a 2.14% drop in the share price the next day.
Here's a look at ResMed's past performance:
| Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|
| EPS Estimate | 1.36 | 1.28 | 1.28 | 1.26 |
| EPS Actual | 1.51 | 1.35 | 1.30 | 1.41 |
| Revenue Estimate | 866.33M | 783.18M | 801.83M | 783.18M |
| Revenue Actual | 904.01M | 876.10M | 768.77M | 800.01M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
